"Albumins" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Water-soluble proteins found in egg whites, blood, lymph, and other tissues and fluids. They coagulate upon heating.
Descriptor ID |
D000418
|
MeSH Number(s) |
D12.776.034
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Albumins".
Below are MeSH descriptors whose meaning is more specific than "Albumins".
This graph shows the total number of publications written about "Albumins" by people in this website by year, and whether "Albumins" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 1 | 0 | 1 |
1995 | 0 | 1 | 1 |
1996 | 1 | 1 | 2 |
1997 | 0 | 2 | 2 |
1998 | 1 | 2 | 3 |
1999 | 2 | 1 | 3 |
2002 | 2 | 2 | 4 |
2003 | 2 | 2 | 4 |
2004 | 1 | 0 | 1 |
2005 | 2 | 3 | 5 |
2006 | 2 | 3 | 5 |
2007 | 1 | 1 | 2 |
2008 | 2 | 2 | 4 |
2009 | 2 | 0 | 2 |
2010 | 1 | 3 | 4 |
2011 | 5 | 0 | 5 |
2012 | 2 | 2 | 4 |
2013 | 0 | 2 | 2 |
2014 | 3 | 2 | 5 |
2015 | 5 | 5 | 10 |
2016 | 2 | 2 | 4 |
2017 | 3 | 1 | 4 |
2018 | 3 | 1 | 4 |
2019 | 2 | 4 | 6 |
2020 | 3 | 1 | 4 |
2021 | 3 | 6 | 9 |
2022 | 1 | 9 | 10 |
2023 | 0 | 6 | 6 |
2024 | 1 | 2 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Albumins" by people in Profiles.
-
Clinical and Genomic Features of Classical and Basal Transcriptional Subtypes in Pancreatic Cancer. Clin Cancer Res. 2024 Nov 01; 30(21):4932-4942.
-
ORIC-101, a Glucocorticoid Receptor Antagonist, in Combination with Nab-Paclitaxel in Patients with Advanced Solid Tumors. Cancer Res Commun. 2024 Sep 01; 4(9):2415-2426.
-
LOAd703, an oncolytic virus-based immunostimulatory gene therapy, combined with chemotherapy for unresectable or metastatic pancreatic cancer (LOKON001): results from arm 1 of a non-randomised, single-centre, phase 1/2 study. Lancet Oncol. 2024 Apr; 25(4):488-500.
-
Development and Validation of the American Heart Association's PREVENT Equations. Circulation. 2024 02 06; 149(6):430-449.
-
Decreased need for RRT in liver transplant recipients after pretransplant treatment of hepatorenal syndrome-type 1 with terlipressin. Liver Transpl. 2024 04 01; 30(4):347-355.
-
NALIRIFOX versus nab-paclitaxel and gemcitabine in treatment-naive patients with metastatic pancreatic ductal adenocarcinoma (NAPOLI 3): a randomised, open-label, phase 3 trial. Lancet. 2023 10 07; 402(10409):1272-1281.
-
NEO-GAP: A Single-Arm, Phase II Feasibility Trial of Neoadjuvant Gemcitabine, Cisplatin, and Nab-Paclitaxel for Resectable, High-Risk Intrahepatic Cholangiocarcinoma. Ann Surg Oncol. 2023 Oct; 30(11):6558-6566.
-
Terlipressin Treatment Is Associated With Reversal of Hepatorenal Syndrome in Patients With Alcoholic Hepatitis. Clin Gastroenterol Hepatol. 2023 12; 21(13):3455-3457.e3.
-
Progression patterns and therapeutic sequencing following immune checkpoint inhibition for hepatocellular carcinoma: An international observational study. Liver Int. 2023 03; 43(3):695-707.
-
Severe hypercholesterolemia in a patient with very low albumin and normal renal function. J Clin Lipidol. 2023 Jan-Feb; 17(1):64-67.